Trials / Sponsors / Fusion Pharmaceuticals Inc.
Fusion Pharmaceuticals Inc.
Industry · 5 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Active Not Recruiting | FPI-2265 (225Ac-PSMA-I&T) and Olaparib for Patients With Metastatic Castration-Resistant Prostate Cancer (mCRP Metastatic Castration-resistant Prostate Cancer | Phase 2 | 2025-02-26 |
| Active Not Recruiting | FPI-2265 (225Ac-PSMA-I&T) for Patients With PSMA-Positive Metastatic Castration-Resistant Prostate Cancer (mCR Metastatic Castration-resistant Prostate Cancer | Phase 2 | 2024-03-05 |
| Terminated | A Study of [225Ac]-FPI-1966 in Participants With Advanced Solid Tumours Advanced Solid Tumor, Head and Neck Squamous Cell Carcinoma, Bladder Carcinoma | Phase 1 / Phase 2 | 2022-04-20 |
| Active Not Recruiting | Targeted Alpha Therapy With 225Actinium-Prostate Specific Membrane Antigen (PSMA)-I&T of Castration-resISTant Metastatic Castration Resistant Prostate Cancer | Phase 2 | 2021-12-16 |
| Terminated | A Phase 1 Study of [225Ac]-FPI-1434 Injection Advanced Solid Tumours, Endometrial Cancer, Cervical Cancer | Phase 1 | 2019-01-17 |